Leclanche SA reported revenue results for the first half of 2016. For the period, the company reported growth in revenue, 65% year-over-year.

Full year 2016, revenues will be approximately CHF 28 million, which is an increase of 55% over 2015. The difference between this and the 100% planned uplift under the Growth Plan is largely attributable to a delay in financial closing of the IESO Canadian Project implying a delay in shipping of goods and a fire at the company's cell manufacturing facility in Germany.


The company aims to achieve EBITDA breakeven in 2018.